AMY PARKER: Open Payments
NPI 1821464256 · MESQUITE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$709 in 31 payments from 15 companies in 2025. Trend: 2023 $606 · 2024 $596 · 2025 $709
Food & beverage: $709
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 1 | $121 |
| Corcept Therapeutics | 3 | $116 |
| Novo Nordisk Inc | 5 | $100 |
| AstraZeneca Pharmaceuticals LP | 6 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| PFIZER INC. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Exact Sciences Corporation | 2 | $30 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Abbott Laboratories | 1 | $22 |
Products named: Korlym, Wegovy, FARXIGA, JARDIANCE, AUSTEDO XR, Cologuard Collection Kit, REZDIFFRA, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
